AGP Executive Report
Last update: 6 hours agoPBS update: Neffy, the adrenaline nasal spray for anaphylaxis, has been added to Australia’s Pharmaceutical Benefits Scheme, giving about 150,000 people access with a $25 dose price—while advocates warn the wider PBS pipeline is still too slow for some patients. Connected care readiness: A new Black Book Market Research report says 99% of providers support connected-care benefits for 1 July 2026 My Health Record share-by-default, but 92% flag practical gaps in workflow, auditability and vendor accountability. Mental health & psychedelics: Optimi Health says it has completed another commercial export of 5mg psilocybin capsules to Australia for treatment-resistant depression, marking its third shipment since launch. First aid & prevention: Mount Gambier councils are urging residents to report thefts of public AED defibrillators after multiple devices were stolen, threatening emergency response in cardiac arrests. Men’s health support: South Australia’s Skylight and local partners are running “Coffee and Chat” sessions for men to encourage connection and discuss wellbeing issues. Bird flu watch: Authorities confirm additional H5 avian flu cases in Australia, with wildlife monitoring ramped up.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.